Literature DB >> 648034

Warfarin sodium: steady-state plasma levels and patient age.

K Hotraphinyo, E J Triggs, B Maybloom, A Maclaine-Cross.   

Abstract

1. Steady-state plasma levels of warfarin were measured in thirty-nine ambulatory patients attending a haematology clinic. 2. Plasma concentrations, plasma clearance, and prothrombin ratio showed no significant differences when patients below 65 years of age were compared with those above 65 years. The mean daily maintenance dose of warfarin required was marginally greater for the younger patients but the difference was not statistically significant (P = 0.10). 3. A significant relationship was found between the daily maintenance dose of warfarin required by all patients and their mean steady-state plasma level (r = 0.5667, P less than 0.001). 4. For one elderly hospitalized patient it was apparent that there was a marked depression of the vitamin K-dependent clotting factor synthesis by warfarin which was associated with a hypoprothrombinaemic response.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648034     DOI: 10.1111/j.1440-1681.1978.tb00664.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

Review 1.  Hepatic drug metabolism and aging.

Authors:  C Durnas; C M Loi; B J Cusack
Journal:  Clin Pharmacokinet       Date:  1990-11       Impact factor: 6.447

2.  Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin.

Authors:  Berit Packert Jensen; Paul Ken Leong Chin; Rebecca Lee Roberts; Evan James Begg
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  Investigation of patients with abnormal response to warfarin.

Authors:  D P Bentley; G Backhouse; A Hutchings; R L Haddon; B Spragg; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1986-07       Impact factor: 4.335

4.  Drugs in the elderly.

Authors:  M M Reidenberg
Journal:  Bull N Y Acad Med       Date:  1980-10

Review 5.  Clinical pharmacokinetics and pharmacodynamics of warfarin. Understanding the dose-effect relationship.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

6.  Population pharmacokinetics of racemic warfarin in adult patients.

Authors:  D R Mungall; T M Ludden; J Marshall; D W Hawkins; R L Talbert; M H Crawford
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

Review 7.  Free drug metabolic clearance in elderly people.

Authors:  Jennifer M Butler; Evan J Begg
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

8.  Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.

Authors:  L Carosella; P Menichelli; M Alimenti; G Zuccala; A Gemma; A Cocchi; P U Carbonin
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.